Table 3.
Ref. | n | Method | Findings or conclusion |
Nanashima et al[25] | 42 | CT | Factor for poor prognosis: case showing arterial enhancement with lower attenuation |
Kim et al[26] | 20 | MRI | 6 (30%) of the 20 cases appeared as hypervascular lesions with washout on delayed phase |
Kang et al[27] | 50 | MRI | Percentage of relative enhancement on hepatobiliary phase was significantly higher in moderately differentiated tumors than in poorly differentiated tumors and in patients without than in those with lymph node metastasis |
Xu et al[28] | 40 | Contrast enhanced ultrasono-graphy | MF-type (n = 32): (1) peripheral rim-like hyperenhancement (n = 19); (2) heterogenous enhancement (n = 10); and (3) homogenous hyperenhancement (n = 3) |
Ariizumi et al[29] | 26 | FDG PET | PI-type (n = 4): heterogenous enhancement (n = 4) IG-type (n = 4): (1) homogenous hyperenhancement (n = 3); and (2) heterogenous enhancement (n = 1) FDG PET was able to predict patient outcome after radioembolization treatment |
CT: Computed tomography; MRI: Magnetic resonance imaging; FDG PET: 18F-fluorodeoxy glucose positron emission tomography.